|
HS Code |
281437 |
| Product Name | Kanamycin Sulfate |
| Cas Number | 25389-94-0 |
| Molecular Formula | C18H36N4O11·H2SO4 |
| Molecular Weight | 582.58 g/mol |
| Synonyms | Kanamycin A Sulfate |
| Appearance | White to off-white powder |
| Solubility | Soluble in water |
| Storage Conditions | 2-8°C, protected from light |
| Purity | ≥98% |
| Antibiotic Class | Aminoglycoside |
| Mode Of Action | Inhibits protein synthesis by binding to 30S ribosomal subunit |
| Application | Antibiotic, selection agent in cell culture |
| Ph Of 10 Percent Solution | 6.0–8.0 |
| Melting Point | Approximately 263°C (decomposes) |
As an accredited Kanamycin Sulfate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Kanamycin Sulfate is packaged in a sealed, amber glass bottle containing 25 grams, labeled with safety information and storage instructions. |
| Shipping | Kanamycin Sulfate is shipped in tightly sealed containers to protect it from moisture and light. The product should be kept at a controlled room temperature during transit. Appropriate labeling and documentation for hazardous materials are included, ensuring compliance with relevant regulations for safe transport of pharmaceutical chemicals. |
| Storage | Kanamycin Sulfate should be stored in a tightly sealed container at 2–8°C (refrigerated) and protected from light and moisture. It should be kept in a well-ventilated area, away from incompatible substances. Avoid exposure to excessive heat. Proper storage maintains its stability and prevents degradation or contamination. Always follow local guidelines and manufacturer's instructions for storage and handling. |
|
Purity 99%: Kanamycin Sulfate with a purity of 99% is used in microbiological media preparation, where it ensures consistent inhibition of susceptible bacterial strains. Molecular Weight 582.58 g/mol: Kanamycin Sulfate with a molecular weight of 582.58 g/mol is used in cell culture selection, where it enables precise dosage calculations for recombinant protein expression systems. Sterility Certified: Kanamycin Sulfate with sterility certification is used in injectable pharmaceutical formulations, where it reduces the risk of contamination in parenteral applications. Water Solubility >50 mg/mL: Kanamycin Sulfate with water solubility greater than 50 mg/mL is used in antibiotic stock solution preparation, where it facilitates rapid and complete dissolution for laboratory workflows. Stability at 25°C: Kanamycin Sulfate stable at 25°C is used in ambient storage conditions for research laboratories, where it maintains antibiotic potency during extended storage. Particle Size <10 µm: Kanamycin Sulfate with a particle size below 10 micrometers is used in veterinary feed additive production, where it ensures homogeneous distribution and bioavailability. Endotoxin Level <0.5 EU/mg: Kanamycin Sulfate with endotoxin levels below 0.5 EU/mg is used in mammalian cell line applications, where it minimizes cytotoxic responses during selection protocols. pH 5.5–7.5 Solution: Kanamycin Sulfate formulated for a pH range of 5.5 to 7.5 is used in bacterial transformation experiments, where it preserves plasmid integrity and selection efficiency. |
Competitive Kanamycin Sulfate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to sales3@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: sales3@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
At our facility, we produce Kanamycin Sulfate that stands out for its purity and reliable performance. In pharmaceutical applications, Kanamycin Sulfate plays a vital role as an aminoglycoside antibiotic, relied on in hospitals and laboratories for its effectiveness against a range of bacterial infections. Years of engineering the process have taught us that consistency matters just as much as final assay results. Granulation, drying, and even the way the raw fermentation broth gets handled on the line, all shape the outcome. That experience forms the backbone of our approach to this compound.
There’s no mistaking the impact of even subtle differences when it comes to injectable-grade antibiotics. Our production adheres to the most stringent cGMP protocols, and that matters for anyone looking to avoid trace contaminants or biologically active impurities. Each batch undergoes microbial testing in our in-house QC labs, checked against pharmacopeial limits. People working with injectable preparations want a translucent powder that dissolves cleanly and handles predictably under real-world mixing conditions. We take these demands seriously—consistency cannot budge.
We manufacture Kanamycin Sulfate as a white to off-white, crystalline, hygroscopic powder. Our experience has shown that controlling moisture and particle size is essential for solubility and batch-to-batch reliability. The standard potency sits in the range of no less than 760 micrograms of Kanamycin per milligram, calculated on the anhydrous basis according to official compendia. Regular monitored levels of moisture, as well as trace solvents or fermentation byproducts, support pharmaceutical manufacturing that avoids surprises.
Long shifts at our site have given us a sharp sense for common pitfalls with this product. Over the years, we've learned that product stiction, changes in residual solvent content, or even a subtle drift in ionic profile can impact both the mixing process in the downstream pharma plant and the ultimate patient experience. Identifying the optimal balance in pH and minimizing color variation has always been part of our routine, aimed at helping formulation chemists and pharmacists achieve hassle-free compounding.
Across the pharmaceutical field, Kanamycin Sulfate sees regular use for treating a variety of infections caused by Gram-negative and some Gram-positive bacteria. Hospitals use it for severe systemic infections, and the compound finds its way into combination regimens for tuberculosis. Veterinary professionals also look for the same dependable quality, relying on the antibiotic’s spectrum for livestock and aquaculture health. Research labs value Kanamycin Sulfate for its role as a selective agent in molecular biology, especially in the development of genetically modified strains and cell cultures resistant to aminoglycoside antibiotics.
One key lesson from our production floor: even after thousands of kilograms produced, strict adherence to validated processes is essential. The stakes remain high, especially for injectable formulations, where even the smallest deviations can influence patient safety or test reproducibility. Our QC staff conduct potency checks using microbiological assay methods tuned for rapid turnaround and accuracy. It’s tempting to cut corners with generic antibiotics, but we know from client feedback and retrospective audits that time saved upfront can cause bigger setbacks if the specification slips.
Within research settings, clarity of source and documentation often matters as much as chemical purity. Our technical team works to provide detailed batch certificates and transparent records of origin, enabling academic and industrial users to plan long-term projects with confidence. This hands-on feedback loop shapes our ongoing improvements and cements our standing as an experienced, process-driven manufacturer.
Many customers ask how Kanamycin Sulfate compares with gentamicin, amikacin, or streptomycin. Each aminoglycoside has its specific spectrum and pharmacological quirks. Kanamycin Sulfate offers a broader profile than streptomycin, hitting a wider panel of pathogens while maintaining clear efficacy in M. tuberculosis regimens. Amikacin provides activity in certain multidrug-resistant organisms where kanamycin may begin to falter, but often comes at a higher cost and with different handling needs in the plant. Gentamicin remains the clinical favorite for some Gram-negative cases, though it brings a different renal toxicity risk profile and interacts differently with cell membranes.
Our teams have seen demand fluctuate between these options as resistance patterns change regionally. Laboratories gravitate toward Kanamycin Sulfate when engineering E. coli or plant cells that require efficient selection without the background resistance sometimes observed with older streptomycin markers. Suppliers offering only generic products often miss the subtleties—such as crystal habit, dissolution kinetics, and even the shelf-life curve—which can make a world of difference to production managers and researchers alike.
In our production records, feedback from long-term customers shows Kanamycin Sulfate as a steady workhorse, with a consistent performance in both clinical and laboratory settings. Not every product achieves this kind of versatility. Having hands-on control over every fermentation lot and fractionation cycle keeps us nimble enough to respond to specialized requirements, whether for compounding, research, or industrial scale-up.
As a manufacturer, we see up close how small changes on the line influence the end result. Batch fermentation demands tight control of substrate quality and environmental parameters. A slight increase in fermentation temperature or substrate impurity can knock off target yields by several percentage points. From raw material receipt through product isolation and neutralization, every stage brings lessons learned—sometimes at considerable cost. Process optimization is not academic for us; it means less waste, smaller environmental footprint, and cleared hurdles for customer regulatory filings.
Our shift managers and QC chemists constantly review critical control points: clarity after dissolution, residual moisture, and absence of detectable endotoxins. Clarity and freedom from visible particles are non-negotiable for injectable uses. Granulation techniques, drying curves, and filter designs all evolve as we gather more data, always focused on making each batch better than the last. Product picked up too early from the dryer brings caking issues later, while overdrying risks a static, hard-to-handle material with poor flow. Old shortcut fixes tend to introduce new headaches.
Our downstream partners benefit because we refuse to compromise on these principles. Over several decades, we've faced off against recalls, sudden regulatory audits, and changing international pharmaceutical regulations. These challenges fuel our commitment to process transparency and ongoing self-improvement. Regular open-door lab visits from customers demonstrate our willingness to show the inner workings of the process and gain unfiltered feedback for further refinement.
We keep a dozen paper and electronic logs for every lot, tracking everything from the inoculum identity to equipment cleaning cycles. Auditors visiting our site see firsthand the strict protocols for avoiding cross-contamination and documenting every processing step. QC samples from every batch undergo not just minimum pharmacopeial testing, but also customer-specific assays when requested. For us, quality assurance has little meaning without tight integration with operations—the lab and the plant have to communicate constantly.
Years of partnership with regulatory authorities and multinational clients have shown the value of this transparency. We routinely share full impurity profiles, residual solvent analysis, and detailed stability curves to support documentation for FDA and EMA filings. Pharmaceutical clients count on documentation that convinces their own internal compliance teams, not generic datasheets or canned assurances.
We also focus on proactive risk management. Chemical manufacturers sometimes overlook the slow creep of process drift—gradual changes in wet milling speed, pipetting precision, or storage humidity that erode reliability over time. Our team holds regular retrospectives, tracking every close call and identifying root causes. No process improvement occurs in a vacuum; new insights from the floor often help customers at the other end of the value chain. Meeting pharmaceutical industry expectations takes a manufacturer’s attention to the details that only come from seeing every batch move from fermenter to final shipment.
Moving large quantities of Kanamycin Sulfate from our plant to customer warehouses is a challenge rarely discussed beyond shipping weight. The product’s hygroscopic nature demands moisture-barrier packaging, but not all plastic drums or foil liners perform equally. A leaky liner or a tear mid-transit means caked product or unplanned downtime at the next facility. Our shipping team learned early on that double-layer packaging, vacuum sealing, and regular feedback from warehouses keeps product losses low and shelf-life curves stable.
We document every packaging trial and keep records for every transit incident. There’s no substitute for watching which packaging types survive the roughest logistics chains and which fail. Temperature spikes along the supply route affect product color and solubility for sensitive customers, especially those in tropical regions. Clear handling instructions and robust materials reduce headaches for receiving staff down the line.
As product ages, careful tracking and retesting for potency, pH, and appearance ensures nothing is released past optimal quality. Customers with controlled storage and prompt inventory rotation rarely experience shelf-life related degradation. In markets where bulk inventory sometimes sits for months, repackaging or re-testing remains available as an added layer of assurance.
Our investment in modern wastewater and air-handling systems comes from understanding how antibiotic manufacturing impacts its surroundings. Each kilogram of Kanamycin Sulfate represents not just a final product, but also responsible management of spent broths and solvents. We use on-site treatments and closed fermentation vessels to limit environmental exposure. Our plant engineers, trained in both process and environmental safety, trace every effluent stream and monitor for any antibiotic residue that could threaten local ecology.
Operators in the plant work with standard protective equipment, and we’ve instituted continuous improvement measures based on years of incident records and safety audits. Kanamycin Sulfate poses moderate risk in bulk, so handling protocols center on preventing inhalation, dust, and contact hazards. Over time, thorough safety briefings and updated incident drills keep the workplace secure—there’s no taking shortcuts where health is at stake.
We also provide guidance to major pharmaceutical buyers and academic institutions on the safe storage and disposal of expired product, supporting lifecycle management from production through to end of use. Shared responsibility extends beyond our plant gate—every manufacturer bears this obligation.
No written document can replace the real-world feedback from researchers, pharmacists, and production managers working with our Kanamycin Sulfate. We’ve spent years developing technical support structures, offering troubleshooting and recommendations based on accumulated practical experience. From handling advice for lyophilized product to solutions for laboratory protocol integration, sharing insights means fewer mistakes on both sides.
Several new product tweaks have come directly from user reports—adjustments in granule size to improve dissolution rates, minor formulation changes to boost storage stability under humid conditions, or documentation upgrades supporting regulatory filings in specific countries. We actively solicit this input, using customer-driven insight to improve both process and product.
Direct communication with users also informs our development pipeline. Recent trends point toward a growing need for antibiotics compatible with advanced genetic engineering vectors. We have responded with lot-specific reporting on resistance profiles and documentation ready for academic and commercial audits. Researchers count on answers that go beyond basic technical data and address practical difficulties encountered in the lab. As a result, we find new ways to keep pace with evolving requirements across clinical, veterinary, and research markets.
Every kilogram of Kanamycin Sulfate that leaves our facility represents more than chemical production. It reflects decades of meticulous process development, lessons earned from setbacks, and active dialogue with the people who use our compound most. Unlike resellers, our team brings first-hand process knowledge to every customer question. From the mechanics of seed tank inoculation to the temperature profiles of our dryers, the entire story is available for review.
Customers gain access to live technical support, batch-specific documentation, and real process transparency—essentials for anyone working under regulatory or research constraints. We continue to refine our product based on real feedback, never relying solely on theoretical optimization. Time spent on process audits, cleaning validation, and trial fermentations all add to the expertise customers draw upon after a single email or call.
Working directly with a manufacturer means having a partner invested in long-term reliability as much as immediate success. Our experience with Kanamycin Sulfate—earned on the production floor, in the lab, and through close customer collaboration—drives us to continue delivering high-quality antibiotic solutions across the globe.